Alice Chen‐Plotkin

20.9k total citations · 1 hit paper
117 papers, 6.1k citations indexed

About

Alice Chen‐Plotkin is a scholar working on Neurology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Alice Chen‐Plotkin has authored 117 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Neurology, 48 papers in Physiology and 34 papers in Psychiatry and Mental health. Recurrent topics in Alice Chen‐Plotkin's work include Parkinson's Disease Mechanisms and Treatments (59 papers), Alzheimer's disease research and treatments (43 papers) and Dementia and Cognitive Impairment Research (33 papers). Alice Chen‐Plotkin is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (59 papers), Alzheimer's disease research and treatments (43 papers) and Dementia and Cognitive Impairment Research (33 papers). Alice Chen‐Plotkin collaborates with scholars based in United States, Spain and Sweden. Alice Chen‐Plotkin's co-authors include John Q. Trojanowski, Virginia M.‐Y. Lee, Michael D. Gallagher, Sharon X. Xie, Daniel Weintraub, Vivianna M. Van Deerlin, Andrew Siderowf, Murray Grossman, Howard I. Hurtig and Travis L. Unger and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Alice Chen‐Plotkin

114 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Post-GWAS Era: From Association to Function

2018 472 citations Alice Chen‐Plotkin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alice Chen‐Plotkin United States	42	3.3k	2.1k	1.8k	932	849	117	6.1k
Tibor Hortobágyi Hungary	43	3.2k 1.0×	2.7k 1.3×	2.2k 1.2×	1.4k 1.5×	908 1.1×	227	8.3k
Claire Troakes United Kingdom	51	3.4k 1.1×	3.7k 1.8×	2.4k 1.3×	1.2k 1.3×	951 1.1×	132	8.2k
Masanori Nakagawa Japan	48	2.4k 0.7×	3.0k 1.4×	1.3k 0.7×	908 1.0×	709 0.8×	324	8.3k
Joanne Wuu United States	48	1.9k 0.6×	1.7k 0.8×	1.7k 1.0×	746 0.8×	906 1.1×	107	6.6k
Yuko Saito Japan	44	2.9k 0.9×	2.0k 1.0×	2.8k 1.6×	1.6k 1.7×	672 0.8×	191	6.6k
Ekaterina Rogaeva Canada	53	3.4k 1.0×	3.6k 1.7×	3.4k 1.9×	1.4k 1.5×	790 0.9×	188	8.3k
Huifang Shang China	40	4.6k 1.4×	1.4k 0.7×	932 0.5×	1.2k 1.3×	697 0.8×	423	7.2k
Johannes Brettschneider Germany	42	3.8k 1.2×	1.6k 0.8×	2.0k 1.1×	1.3k 1.4×	814 1.0×	90	6.5k
Christian Barro Switzerland	34	2.9k 0.9×	1.8k 0.9×	912 0.5×	869 0.9×	662 0.8×	72	7.2k
Stefan Vielhaber Germany	45	2.7k 0.8×	2.1k 1.0×	1.3k 0.7×	576 0.6×	565 0.7×	166	5.8k

Countries citing papers authored by Alice Chen‐Plotkin

Since Specialization

Citations

This map shows the geographic impact of Alice Chen‐Plotkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Chen‐Plotkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Chen‐Plotkin more than expected).

Fields of papers citing papers by Alice Chen‐Plotkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Chen‐Plotkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Chen‐Plotkin. The network helps show where Alice Chen‐Plotkin may publish in the future.

Co-authorship network of co-authors of Alice Chen‐Plotkin

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Chen‐Plotkin. A scholar is included among the top collaborators of Alice Chen‐Plotkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Chen‐Plotkin. Alice Chen‐Plotkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vermunt, Lisa, Carel F.W. Peeters, Emma L. van der Ende, et al.. (2025). Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia. Molecular Neurodegeneration. 20(1). 93–93. 1 indexed citations

Zhang, Hanwen, Daniel Kargilis, Thomas F. Tropea, et al.. (2025). Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes. Annals of Clinical and Translational Neurology. 12(5). 925–937. 1 indexed citations

Cousins, Katheryn A Q, Jeffrey S. Phillips, Sandhitsu R. Das, et al.. (2024). Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative disease. Alzheimer s & Dementia. 20(6). 3889–3905. 16 indexed citations

Ende, Emma L. van der, Sjors G. J. G. In ‘t Veld, Sven J. van der Lee, et al.. (2023). CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease. Brain. 146(11). 4495–4507. 27 indexed citations

Campo, Marta del, Lisa Vermunt, Carel F.W. Peeters, et al.. (2023). CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease. Nature Communications. 14(1). 5635–5635. 31 indexed citations

Couto, Blas, Mário Sousa, Paulina González-Latapí, et al.. (2023). Disease Progression and Sphingolipids and Neurofilament Light Chain in Early Idiopathic Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51(4). 573–576. 3 indexed citations

Ende, Emma L. van der, Sjors G. J. G. In ‘t Veld, Janna I.R. Dijkstra, et al.. (2023). CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease. Alzheimer s & Dementia. 19(S14). 1 indexed citations

Cousins, Katheryn A Q, Sanjana Shellikeri, Daniel T. Ohm, et al.. (2022). CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology. Neurology. 99(20). e2303–e2312. 13 indexed citations

Wie, Jinhong, Zhenjiang Liu, Thomas F. Tropea, et al.. (2021). Author Correction: A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology. Nature. 592(7855). E10–E10. 3 indexed citations

10.

Wie, Jinhong, Zhenjiang Liu, Thomas F. Tropea, et al.. (2021). A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology. Nature. 591(7850). 431–437. 86 indexed citations

11.

Breazzano, Mark P., Aliaa H. Abdelhakim, Lora R. Dagi Glass, et al.. (2020). New York City COVID-19 resident physician exposure during exponential phase of pandemic. Journal of Clinical Investigation. 130(9). 4726–4733. 56 indexed citations

12.

Rick, Jacqueline, Sharon X. Xie, Pablo Martínez‐Martín, et al.. (2020). Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease. Journal of Parkinson s Disease. 11(2). 737–745. 5 indexed citations

13.

Akhtar, Rizwan, Sharon X. Xie, Jacqueline Rick, et al.. (2017). Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia. PLoS ONE. 12(5). e0177924–e0177924. 31 indexed citations

14.

Roalf, David R., Tyler M. Moore, David A. Wolk, et al.. (2016). Defining and Validating a Short Form Montreal Cognitive Assessment (s-MoCA) for Use in Neurodegenerative Disease (S1.005). Neurology. 86(16_supplement). 1 indexed citations

15.

Chahine, Lana M., Matthew B. Stern, & Alice Chen‐Plotkin. (2013). Blood-based biomarkers for Parkinson's disease. Parkinsonism & Related Disorders. 20. S99–S103. 117 indexed citations

16.

Wood, Elisabeth McCarty, Dana Falcone, EunRan Suh, et al.. (2013). Development and Validation of Pedigree Classification Criteria for Frontotemporal Lobar Degeneration. JAMA Neurology. 70(11). 1411–1411. 93 indexed citations

17.

Siderowf, Andrew, Sharon X. Xie, Howard I. Hurtig, et al.. (2010). CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease. Neurology. 75(12). 1055–1061. 281 indexed citations

18.

Hu, William T., Alice Chen‐Plotkin, Owen A. Ross, et al.. (2010). Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology. 75(23). 2079–2086. 74 indexed citations

19.

Kesari, Santosh, David Schiff, Lisa Doherty, et al.. (2007). Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Neuro-Oncology. 9(3). 354–363. 92 indexed citations

20.

Chen‐Plotkin, Alice, Ghazaleh Sadri‐Vakili, George J. Yohrling, et al.. (2006). Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease. Neurobiology of Disease. 22(2). 233–241. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact